Pharmafile Logo
Pharmafocus logo
Advanced Search

hepc

Showing 5 posts of 5 posts found.

Harvoni image

Gilead gets Harvoni boost for Europe

November 20, 2014
Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi

Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …

News
sovaldi image

Gilead’s $1,000 per day Hep C drug approved

December 9, 2013
Sales and Marketing FDA, Gilead, hepc, sofosbuvir, sovaldi

Gilead’s Sovaldi has gained FDA approval as a potential cure for hepatitis C after the US regulator sped up its …

News

EMA speeds up Boehringer review

November 28, 2013
Sales and Marketing Boehringer, faldaprevir, hepc

Boehringer Ingelheim’s hepatitis C candidate faldaprevir has moved a potential step closer to market with the news that the European …

News
Gilead image

Gilead runs into India patent trouble

November 26, 2013
Sales and Marketing Gilead, MSF, hepc, sofosbuvir, sovaldi

Gilead Sciences has run into heavy traffic in India as campaigners attempt to block the company’s patent there on new …

News
janssen image

FDA approves Olysio

November 25, 2013
Sales and Marketing FDA, Janseen, Janssen, hep C, hepc, olysio, simeprevir

US regulators have approved Janssen Pharmaceuticals’ Olysio, a new therapy to treat chronic hepatitis C virus infection, after a priority …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026